Filing Details
- Accession Number:
- 0001179110-15-013022
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-03 15:07:19
- Reporting Period:
- 2015-09-02
- Filing Date:
- 2015-09-03
- Accepted Time:
- 2015-09-03 15:07:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1327145 | L Robin Washington | Gilead Sciences, Inc. 333 Lakeside Drive Foster City CA 94404 | Evp, Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-09-02 | 3,000 | $101.75 | 97,546 | No | 4 | S | Indirect | Trust |
| Common Stock | Disposition | 2015-09-02 | 3,150 | $102.60 | 94,396 | No | 4 | S | Indirect | Trust |
| Common Stock | Disposition | 2015-09-02 | 100 | $103.41 | 94,296 | No | 4 | S | Indirect | Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Trust |
| No | 4 | S | Indirect | Trust |
| No | 4 | S | Indirect | Trust |
Footnotes
- The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- Sale prices reported for the transactions reported here range from $101.16 to $102.12. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $102.22 to $103.06. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
